SPECIAL DAY/WEEK/MONTH: Designates May 2026, as Amyotrophic Lateral Sclerosis Awareness Month.
Summary
Senate Resolution 100 is a commemorative resolution that recognizes May 2026 as Amyotrophic Lateral Sclerosis (ALS) Awareness Month in Louisiana. The resolution describes ALS, also known as Lou Gehrig’s disease, as a fatal neurodegenerative condition that progressively impairs movement, speech, eating, and breathing, and it highlights the urgency of research, treatment access, and support for affected individuals and families.
The resolution emphasizes the need for public awareness, clinical trials, assistive technologies, durable medical equipment, and access to new therapies for people living with ALS. It also notes the role of the ALS Association in funding research and providing support services, and it specifically references the elevated risk of ALS among military veterans. The resolution concludes by transmitting a copy to the ALS Association.
Impact
SR100 does not amend or create any statutory law, impose regulatory requirements, or appropriate funds. Its legal effect is limited to an official legislative recognition of May 2026 as ALS Awareness Month and a formal expression of support for ALS research, patient assistance, and public education. The resolution primarily affects symbolic state action and outreach to advocacy organizations rather than changing the rights or obligations of any person or agency.
Sentiment
The sentiment around the resolution is strongly supportive and commemorative. The bill text frames ALS as a devastating disease and presents awareness month as an opportunity to honor those affected, increase public understanding, and affirm commitment to finding a cure. No opposition, dissent, or recorded vote controversy appears in the provided materials, and the resolution was enrolled and sent to the Secretary of State, indicating smooth passage.
Contention
No notable contention is reflected in the available record. Because the measure is a nonbinding resolution, there is no apparent dispute over legal mandates, spending, or enforcement. The only substantive policy themes are support for ALS research, access to therapies and equipment, and recognition of the disease’s impact on veterans and families, all of which are presented in a uniformly favorable manner.